Study guide
4.3 Mandatory Electronic Prescribing of Controlled Substances (EPCS) in Utah
Utah MPJE Pharmacy Jurisprudence Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Utah Pharmacy Regulatory Framework, Facility Licensing & the PIC
1.1 DOPL, the Utah State Board of Pharmacy & the Sources of Utah Pharmacy Law 1.2 Federal vs. Utah Law: Following the Stricter Standard 1.3 Utah Pharmacy License Classes (A–E) & Facility Licensing 1.4 The Pharmacist-in-Charge (PIC): Duties, Self-Audits & Notifications 1.5 Facility Inspections, Ownership & Location Changes, Closing & Facility Discipline
2 Chapter 2: Pharmacist, Intern & Technician Licensure and Personnel
2.1 Pharmacist Licensure, the NAPLEX & Utah MPJE, and Licensure by Endorsement 2.2 License Renewal, Continuing Education & Reinstatement 2.3 Pharmacy Interns & Preceptors 2.4 Pharmacy Technicians, Technician Trainees & Supportive Personnel
3 Chapter 3: Unlawful & Unprofessional Conduct, Discipline, and Impairment
3.1 Unlawful Conduct, Criminal Penalties, Fines & the Disciplinary Process 3.2 Unprofessional Conduct, the APhA Code of Ethics & Utah's Conscience Law 3.3 Impairment, the Utah Professionals Health Program & Reinstatement
4 Chapter 4: Prescription Issuance, Prescriber Authority & Electronic Prescribing
4.1 Prescriber Scope of Authority in Utah 4.2 Required Prescription Elements, Oral & Faxed Orders, and Alterations 4.3 Mandatory Electronic Prescribing of Controlled Substances (EPCS) in Utah 4.4 Legitimate Medical Purpose, Corresponding Responsibility & Red Flags
5 Chapter 5: Patient Counseling, Prospective DUR, Confidentiality & Records
5.1 Patient Counseling: The Offer, Who May Counsel & Delivered Prescriptions 5.2 Prospective Drug Utilization Review & Patient Medication Profiles 5.3 Confidentiality, HIPAA & Protected Health Information 5.4 Pharmacy Records, Retention Periods & Facility Operating Standards
6 Chapter 6: Expanded Practice: Collaboration, Pharmacist Prescribing & Drug Administration
6.1 Collaborative Pharmacy Practice, Drug Therapy Management & Administration of Drugs 6.2 Self-Administered Hormonal Contraception: Standing Order & Pharmacist Prescribing 6.3 Pharmacist Prescribing Under Utah Code § 58-17b-627: Tobacco Cessation, HIV PrEP/PEP, Fluoride & Epinephrine 6.4 Vaccine Administration: DOPL's Protocol, Delegation, Emergencies & USIIS Reporting
7 Chapter 7: Opioid Overdose Prevention, Emergency Refills & Returned or Donated Drugs
7.1 Naloxone & Opioid-Safety Laws in Utah 7.2 Emergency Refills, Combined Refills & Insulin Continuity 7.3 Returned Drugs, Consumer Disposal & the Charitable Prescription Drug Recycling Program
8 Chapter 8: Controlled Substance Schedules, Registration & Security in Utah
8.1 Controlled Substance Schedules: Federal CSA & Utah-Specific Scheduling 8.2 DEA Registration & Facility Licensing 8.3 Controlled Substance Storage & Physical Security
9 Chapter 9: Dispensing Controlled Substances & the Utah Controlled Substance Database
9.1 Schedule II Prescriptions: 30-Day Window, One-Month Supply, Multiple Prescriptions & the 7-Day Acute Limit 9.2 Schedule II Partial Fills, Emergency Oral Orders & Methadone Emergency Orders 9.3 Schedule III–V Prescriptions: Refill Limits, the 80% Rule & Controlled Substance Transfers 9.4 The Utah Controlled Substance Database (CSD)
10 Chapter 10: Dispensing Standards: Labeling, Substitution, Refills, Packaging, Product Integrity & OTC Products
10.1 Prescription Labels: Utah Minimum Elements, Controlled Substance & Opioid Warnings, and Special Labels 10.2 Drug Product Selection: Generic Equivalents, Therapeutically Similar Drugs & Interchangeable Biologics 10.3 Legend-Drug Prescription Validity, Refills & Transfers 10.4 Poison Prevention Packaging Act (PPPA) & Special Packaging 10.5 Drug Product Conditions That Prohibit Dispensing: Adulterated, Misbranded, Outdated, Recalled & Suspect Products 10.6 Nonprescription Products: OTC Labeling & Packaging, Pseudoephedrine, Iodine, Schedule V & Other Restricted OTC Sales
11 Chapter 11: Acquisition, Inventory, Loss, Distribution & Delivery
11.1 Ordering Schedule II Substances: DEA Form 222 & CSOS 11.2 Controlled Substance Inventories & Utah's Schedule II Perpetual Inventory 11.3 Theft, Significant Loss & Disposal of Controlled Substances 11.4 Drug Acquisition & Distribution, Office-Use Sales, and Delivering Prescriptions to Patients
12 Chapter 12: Compounding Standards, USP Chapters & Hazardous Drugs
12.1 Non-Sterile Compounding & USP <795> Standards 12.2 Sterile Compounding & USP <797> Standards 12.3 Hazardous Drug Handling & USP <800> Standards
13 Chapter 13: Institutional, Central Processing, Remote Dispensing, Specialty Outlets & Automation
13.1 Institutional Practice: Hospitals, Pharmaceutical Administration Facilities & Emergency Drug Kits 13.2 Centralized Prescription Processing, Telepharmacy & Remote Dispensing Pharmacies 13.3 Nuclear Pharmacies, Class E Outlets & Dispensing Medical Practitioners 13.4 Automated Pharmacy Systems, Quality Assurance & Pharmacy Audits
4.3 Mandatory Electronic Prescribing of Controlled Substances (EPCS) in Utah
Key Takeaways Explain This Topic AI
Utah Code § 58-37-302 has required controlled substance prescriptions to be transmitted electronically since January 1, 2022, unless an exemption applies.
Statutory EPCS exemptions cover patients in assisted living, long-term care, or correctional facilities; veterinarians; VA pharmacies; temporary technical failures; and emergencies.
A prescriber who issues 300 or fewer controlled substance prescriptions per year or 25 or fewer per month is automatically exempt from Utah EPCS (R156-37-610).
A pharmacist who receives a written, oral, or faxed controlled substance prescription is not required to verify that it qualifies for an EPCS exemption (R156-37-609(2)).
Since July 1, 2024, Utah pharmacy software must be able to transfer an unfilled electronic controlled substance prescription to another pharmacy on request, with the originating pharmacist's approval (Utah Code § 58-37-302(3)).
Last updated: September 2026
4.3 Mandatory Electronic Prescribing of Controlled Substances (EPCS) in Utah
Utah's EPCS mandate was formerly in § 58-37-22. Since July 1, 2026 it is in § 58-37-302 . It puts the duty on the prescriber , and the rules give pharmacists specific protections and protocols.
The mandate (§ 58-37-302(1))
Beginning January 1, 2022 , each prescription for a controlled substance in any schedule (II–V) must be transmitted electronically unless it is:
- (a) for a patient residing in an assisted living facility, long-term care facility, or correctional facility ;
- (b) issued by a veterinarian ;
- (c) dispensed by a Department of Veterans Affairs pharmacy ;
- (d) issued during a temporary technical or electronic failure at the practitioner's or pharmacy's location; or
(e) issued in an emergency situation .
Since Utah made gabapentin Schedule V in 2024, gabapentin prescriptions are also subject to EPCS.
Additional exemptions by rule (R156-37-609(3); R156-37-610)
A prescriber or pharmacy is also exempt if the exemption is documented on the prescription's hard copy and:
- the prescriber is licensed outside Utah and the pharmacy orally confirms the prescription with the prescriber;
- the prescriber and dispensing pharmacy are the same entity ;
- the prescription is a Schedule II oral emergency prescription under R156-37-605;
- the FDA requires elements that cannot be included electronically;
- the drug is under a research protocol ;
- the prescription requires compounding two or more ingredients ;
the prescriber or pharmacy is in an area CMS has identified as a qualifying emergency or disaster on its EPCS website; or
the prescriber qualifies for the small prescriber exemption : 300 or fewer CS prescriptions per calendar year or 25 or fewer per month. Exempt prescriptions and most refills don't count toward these totals. Prescribers don't register for this exemption; DOPL measures it by NPI using CSD data, and it may revoke eligibility by notice.
What counts as an "emergency" and a "technical failure" (R156-37-102)
An emergency situation exists when a CS prescription cannot be issued or transmitted electronically without a delay that would adversely affect the patient's condition, and prompt prescribing or dispensing is necessary. It includes urgent prescribing when the prescriber cannot reasonably transmit to the patient's pharmacy, and after-hours situations (weekends, holidays, overnight) when the patient cannot get to a 24-hour pharmacy or their regular pharmacy.
A technical difficulty or electronic failure means a loss of power or internet service, or a failure of a computer system, application, or device, that reasonably prevents the prescriber from transmitting, the pharmacy from receiving or forwarding, or either from complying with law (including 21 CFR Part 1311).
When a prescriber or pharmacy relies on a technical failure, the nature of the failure must be documented on the prescription's hard copy (R156-37-609(1)). A prescriber or pharmacy that fails to try to fix a technical problem reasonably within its control commits unprofessional conduct (R156-37-502(10)–(11)).
The pharmacist's position
Important
A pharmacist who receives a written, oral, or faxed CS prescription is not required to verify that it qualifies for an exemption, and may dispense from an otherwise valid prescription (R156-37-609(2)). The EPCS duty belongs to the prescriber.
This does not replace the pharmacist's other duties. The prescription still must be complete, lawful, and issued for a legitimate medical purpose (see Section 4.4).
When the pharmacy can't fill an electronic CS prescription (R156-37-609(4))
Situation What the pharmacy does
It can electronically forward the prescription Contact the patient to choose a receiving pharmacy, and document in the system which pharmacy received the forwarded prescription
It cannot electronically forward Tell the prescriber it cannot fill or transmit the prescription, document the person contacted, and void the prescription. The prescriber may then send a new e-prescription to a different pharmacy.
Since July 1, 2024 , pharmacy software receiving electronic CS prescriptions must be able to electronically transfer an unfilled prescription to a different pharmacy on request of the patient or practitioner, with approval of a pharmacist at the originating pharmacy (§ 58-37-302(3)). This matches DEA's 2023 rule allowing a one-time transfer of an unfilled electronic CS prescription , including Schedule II, between pharmacies (21 CFR 1306.08(e), 1306.25).
Federal EPCS security (21 CFR Part 1311)
The prescriber's application and the pharmacy application must be certified by a third party (or audited) as meeting DEA requirements.
Prescribers undergo identity proofing through an approved credential service provider.
Logical access controls set signing permissions, with two individuals involved in granting access.
Signing requires two-factor authentication using two of three factor types: something you know (password or PIN), something you have (a hard token separate from the computer), and something you are (biometric). Two knowledge factors do not satisfy the rule.
The pharmacy application must digitally sign, or receive and archive, the prescription and keep audit trails .
DOPL rules incorporate Part 1311: electronic CS prescriptions must be issued and dispensed in accordance with it (R156-37-609(5)).
Scenarios
A surgeon's EHR goes down during a storm. The surgeon writes a paper hydrocodone/acetaminophen prescription and notes the outage. The pharmacist may fill it without independently verifying the outage.
A dentist who writes about 15 CS prescriptions a month issues a paper prescription for a CIV drug. This is likely covered by the small-prescriber exemption, and the pharmacist need not verify.
A patient asks to move an unfilled e-prescription for methylphenidate to another pharmacy. Federal rules allow a one-time transfer of the unfilled electronic prescription. Utah requires software capable of it, with the originating pharmacist's approval.